Table 2.
Relative expression of transcripts (listed alphabetically) identified from whole skeletal muscle potentially affected by aging and/or exercise using a RT RT-PCR screening method
Young | Elderly | ||||
---|---|---|---|---|---|
Transcript, Accession No. | Ct | Pre | Post | Pre | Post |
α-Cardiac actin (ACTC1), NM_005159 | 23.94 | 1.0 | 8.0 | 1.4 | 3.1 |
Atrogin-1 or F-box protein 32 (MAFbx), NM 058229 | 28.9 | 1.0 | 0.8 | 0.4 | 0.5 |
Ciliary neurotrophic factor (CNTF) NM 000614 | 28.18 | 1.0 | 1.2 | 0.5 | 0.7 |
Connective tissue growth factor (CTGF), NM_001901 | 27.04 | 1.0 | 0.6 | 0.6 | 0.5 |
Early growth response protein-1 (EGR1), NM 001964 | 26.99 | 1.0 | 1.8 | 0.6 | 0.6 |
Fibroblast growth factor-6 (FGF6), NM_020996 | 26.02 | 1.0 | 1.3 | 0.5 | 0.9 |
Fibronectin (FN1), X02761 | 25.57 | 1.0 | 0.6 | 0.1 | 0.3 |
Growth and differentiation factor 8 or myostatin (GDF8), NM_005259 | 25.54 | 1.0 | 0.5 | 0.5 | 0.4 |
Insulin-like growth factor binding protein-5 (IGFBP5), NM_000599 | 21.66 | 1.0 | 0.8 | 0.5 | 0.6 |
Insulin-like growth factor-1 (IGF1), NM_000618 ‘ | 27.71 | 1.0 | 0.6 | 0.3 | 0.4 |
Matrix metallopeptidase-2 (MMP2), NM_004530 | 25.06 | 1.0 | 1.3 | 0.5 | 0.8 |
Osteosarcoma viral oncogene homolog (c-fos), AY212879 | 29.33 | 1.0 | 0.9 | 0.3 | 0.4 |
TIMP metallopeptidase inhibitor-1 (TIMP1), X03124 | 27.83 | 1.0 | 2.4 | 0.9 | 1.4 |
Vascular endothelial growth factor-A (VEGFA), M32977 | 25.38 | 1.0 | 1.2 | 0.5 | 0.9 |
Vascular endothelial growth factor-D (VEGFD), NM_004469 | 28.26 | 1.0 | 0.9 | 0.5 | 0.6 |
Transcript name, abbreviation, and sequence are available using the provided accession number at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=gene. Ct is threshold real-time (RT) RT-PCR cycle for detection of transcript in young muscle pre-exercise pool. Transcript levels are presented as the fold-difference relative to the young muscle pre-exercise pool with differences ≤0.5 or ≥1.5 in boldface. Pre, pre-exercise; Post, post-exercise.